Cue Biopharma Inc reports results for the quarter ended in September - Earnings Summary

Cue Biopharma

14/11/2022 22:48

* Cue Biopharma Inc  CUE.OQ  reported a quarterly adjusted
loss
of 31 cents​​ per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 38 cents per share.
    * Revenue fell 97.2% to $68.00 thousand from a year ago;
analysts
expected $440.33 thousand. 
    * Cue Biopharma Inc's reported EPS for the quarter was a
loss
of 31 cents​.
    * The mean earnings estimate of analysts had risen by
about 4.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Cue Biopharma Inc shares had risen by 40.8% this
quarter and
lost 72.2% so far this year.
    * The company reported a quarterly loss of $10.96 million.
    * Wall Street's median 12-month price target for Cue
Biopharma Inc
is $12.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 10:47 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.38          -0.31          Beat
 Jun. 30 2022      -0.42          -0.37          Beat
 Mar. 31 2022      -0.43          -0.44          Missed
 Dec. 31 2021      -0.38          -0.25          Beat